港股異動 | 錦欣生殖漲超5%,央行論文稱應全面放開和鼓勵生育
uSMART盈立智投4月15日消息,週四港股早盤,錦欣生殖跳空高開,逆市上漲,截至9:40,錦欣生殖盤中漲超5%。
4月14日,央行發表題爲《關於我國人口轉型的認識和應對之策》的工作論文,應全面放開和鼓勵生育,完善養老制度。
央行工作論文提出,我國要認清人口形勢已經改變,要認識到人口紅利當時用得舒服,事後是需要償還的負債;要認識到人口慣性是跨代際的巨大力量,其反作用力將導致人口反方向變化;要認識到教育和科技進步難以彌補人口的下降。爲此,應全面放開和鼓勵生育,切實解決婦女在懷孕、生產、入託、入學中的困難,綜合施策,久久爲功,努力實現 2035 年遠景規劃和百年奮鬥目標。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.